Quantcast
Last updated on April 16, 2014 at 13:58 EDT

Latest Organofluorides Stories

2013-11-13 23:03:32

The Firm is now investigating Lipitor lawsuits on behalf of individuals who developed new-onset Type 2 diabetes, allegedly due to their use of Lipitor. (PRWEB) November 13, 2013 Lipitor lawsuits (http://www.thelipitorlawsuit.com/) continue to mount in courts around the country, as Bernstein Liebhard LLP notes the filing of a new claim in West Virginia Federal Court on behalf of a woman who allegedly developed new-onset Type 2 diabetes due to her use of the cholesterol –lowering drug....

2013-11-13 23:02:14

The Firm is evaluating Risperdal lawsuits on behalf of alleged victims of Risperdal and male breast growth. New York, New York (PRWEB) November 13, 2013 At least 250 Risperdal lawsuits (http://www.therisperdallawsuit.com/), many involving allegations that the use of the antipsychotic drug caused boys to develop gynecomastia, or male breast growth, are currently pending in a litigation underway in Pennsylvania’s Philadelphia Court of Common Pleas, Bernstein Liebhard LLP reports....

2013-11-12 23:00:24

DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) November 12, 2013 The diabetes drug safety center at DrugRisk.com is alerting patients taking the medications Januvia or Janumet of new information on the site. A federal court overseeing a growing number of lawsuits alleging drugs like these caused pancreatic cancer has set the next hearing for next week. The formal case is...

2013-11-09 23:01:50

The Firm is actively investigating potential Januvia lawsuit claims on behalf of individuals who allegedly developed pancreatitis, pancreatic cancer or thyroid cancer due to their use of the Type 2 diabetes medication. New York, New York (PRWEB) November 09, 2013 The federal multidistrict litigation established for Januvia lawsuits (http://www.januvialawsuithelp.com) will hold its next Status Conference on November 21, 2013, Bernstein Liebhard LLP reports. According to court filings, at...

2013-11-08 23:22:57

List includes life-threatening condition PPHN and other defects. Resource4thePeople's national network of attorneys maintain offer of free consultations to families with children allegedly suffering birth defects after use of SSRIs during pregnancies. San Diego, CA (PRWEB) November 08, 2013 http://www.resource4thepeople.com/defectivedrugs/SSRI-Birth-Defects.html Resource4thePeople announced today a detailed list of the types of birth defects that its national network of lawyers are...

2013-11-08 23:03:50

The firm is currently offering Risperdal lawsuit evaluations to those who allege that they suffered from the drug’s alleged side effects. (PRWEB) November 08, 2013 Drug maker Johnson & Johnson has agreed to pay $2.2 billion in civil and criminal fines to settle claims it improperly marketed the antipsychotic medication Risperdal to children, seniors and people with developmental disabilities. The Rottenstein Law Group LLP, which represents clients in Risperdal lawsuits, notes that...

2013-11-08 23:01:50

The Firm is evaluating potential Lipitor lawsuits that allege an association between the use of Lipitor and diabetes. New York, New York (PRWEB) November 08, 2013 As Lipitor lawsuit (http://www.thelipitorlawsuit.com/) claims involving allegations that the cholesterol-lowering medication caused users to develop type 2 diabetes continue to mount in federal courts throughout the U.S., Bernstein Liebhard LLP notes that Pfizer, Inc. has voiced opposition to the creation of a multidistrict...

2013-11-07 12:28:12

New targeted treatment delays lung cancer tumour progression and improves disease related symptoms versus standard chemotherapy(i) BURLINGTON, ON, Nov. 7, 2013 /CNW/ - Boehringer Ingelheim (Canada) Ltd. announced today that Health Canada has approved GIOTRIF(®) (afatinib) tablets for oral use, as a new treatment for Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitor naïve patients with metastatic (including cytologically proven pleural effusion) adenocarcinoma of...

2013-11-06 23:18:48

The SAE MAC Refrigerant Blend Cooperative Research Program [MRB CRP] has continued its assessment of the operating, technical, and safety performance of low GWP refrigerants. Warrendale, Pa. (PRWEB) November 06, 2013 The SAE MAC Refrigerant Blend Cooperative Research Program [MRB CRP] has continued its assessment of the operating, technical, and safety performance of low GWP refrigerants. At meetings held in Troy, Michigan, on 20-21 October, all outstanding aspects of the project were...

2013-11-05 23:26:47

The Agreement Settles Charges that Johnson & Johnson Illegally Marketed Risperdal, Invega and Natracor for Off-Label Use and Paid Kick-Backs to Physicians to Drive Sales of Risperdal and Invega, Alonso Krangle LLP reports. New York, NY (PRWEB) November 05, 2013 Johnson & Johnson has agreed to pay $2.2 billion to settle charges with the U.S. Department of Justice (DOJ) over the alleged illegal marketing of Risperdal, Invega and Natrecor, Alonso Krangle LLP reports. In a press...